𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoea

✍ Scribed by J. C. Cooper; Mr N. S. Williams; R. F. G. J. King; M. C. J. Barker

Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
519 KB
Volume
73
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of somatostatin and a long-actin
Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat
✍ Mr J. N. Baxter; S. A. Jenkins; D. W. Day; N. B. Roberts; D. C. Cowell; C. R. Ma πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 423 KB πŸ‘ 1 views

The effects of somatostatin (SRIF) and its long-acting analogue, SMS 201-995 on the prevention and treatment of acute pancreatitis were studied in rats. Acute pancreatitis was established by ligating the bile duct at the point of entry into the duodenum, thereby allowing reflux of bile into the panc

Long-term effects of LDL apheresis in pa
Long-term effects of LDL apheresis in patients with severe hypercholesterolemia
✍ Bruce S. Sachais; Julie Katz; Joyce Ross; Daniel J. Rader πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 1 views

Familial hypercholesterolemia (FH) is an inherited disorder of lipoprotein metabolism involving mutations in the LDL receptor (LDL-R). Patients with mutation in one (heterozygous) or both (homozygous) genes have markedly elevated LDL cholesterol and are at increased risk for coronary heart disease (

A phase III evaluation of a somatostatin
A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma
✍ David L. Morris πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 3 views

I of a Somatostatin Analogue (Octreotide) in the Treatment of Patients with Asymptomatic Advanced Colon Cancer."' The disappointing results of this study contrast with recently reported cellular kinetic data for rectal cancer treatment with somatostatin. It should be noted that the dosage used in o